Neuland Laboratories

Neuland Laboratories

13,017.00
-264.00
(-1.99%)
ann
Q1 Quarterly Results are out. Check out the updated financials2 days ago
Viewcross
right
Market Cap
16,700.70 Cr
EPS
202.74
PE Ratio
126.97
Dividend Yield
0.09 %
Industry
Healthcare
52 Week High
18,100.00
52 Week Low
8,756.00
PB Ratio
10.98
Debt to Equity
0.09
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
neutral
Neuland Labs reported weak quarterly results but confirmed its full-year growth plans remain intact. The company is increasing investments in high-profit Contract Development and Manufacturing Organization (CDMO) services, specialty APIs, and peptide production. These investments aim to capitalize on global outsourcing demand and expand the company's pipeline.
negative
Neuland Laboratories announced its unaudited financial results for the quarter ended June 30, 2025. The company reported standalone revenue from operations of ₹29,275.27 lakhs compared to ₹43,960.17 lakhs in the same quarter last year, representing a decline. Profit for the period was ₹1,370.76 lakhs versus ₹9,833.93 lakhs in the previous year quarter. On a consolidated basis, revenue from operations was ₹29,275.27 lakhs against ₹43,960.17 lakhs in the corresponding quarter. The company's board also approved the reappointment of Dr. Ravi Shankar Gopinath as an Additional Director categorized as Independent for a five-year term from August 1, 2025, subject to shareholder approval. Dr. Gopinath has over 30 years of global experience in scaling businesses and holds a Ph.D. in Chemical Engineering from Rensselaer Polytechnic Institute.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,629.70
#1 3,91,019.60
34.07
#1 54,729.00
9.71
#1 10,980
-19.84
36.52
6,361.50
1,68,877.80
77.07
9,712.00
0.89
2,191
23.05
30.87
3,678.20
1,24,487.00
61.58
11,539.40
6.99
1,911
19.91
66.62
1,502.80
1,21,382.30
22.49
28,409.50
7.12
5,291
9.88
48.02
2,566.30
1,05,918.60
55.95
12,744.20
#1 20.90
2,007
-18.14
54.69
1,220.60
1,01,867.70
#1 17.92
33,741.20
16.73
5,725
1.26
35.90
949.05
95,496.60
20.54
23,511.00
13.82
4,615
-0.19
40.50
1,867.30
85,278.70
26.24
22,909.50
19.94
3,306
#1 112.49
37.22
33,595.00
71,387.00
50.58
6,684.70
10.80
1,414
27.83
48.05
1,079.80
62,715.00
18.15
31,378.10
17.55
3,366
-0.50
36.97
Forecast
Actual
Growth Rate
Revenue Growth
-4.70 %
Net Income Growth
-13.33 %
Cash Flow Change
21.52 %
ROE
-27.06 %
ROCE
-30.03 %
EBITDA Margin (Avg.)
-24.07 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
155
169
172
174
182
187
205
193
206
242
246
259
203
258
238
257
222
294
270
415
365
421
395
390
465
315
458
336
301
Expenses
145
154
156
154
162
161
176
162
172
201
199
219
175
215
204
217
193
224
215
287
266
280
272
278
316
249
311
277
258
EBITDA
10
15
16
20
19
26
29
32
35
42
47
40
28
43
34
40
29
70
55
128
99
141
123
112
149
67
146
59
42
Operating Profit %
6 %
9 %
9 %
11 %
10 %
13 %
14 %
16 %
16 %
17 %
19 %
10 %
13 %
17 %
14 %
15 %
13 %
24 %
20 %
29 %
27 %
33 %
31 %
28 %
28 %
20 %
22 %
16 %
12 %
Depreciation
6
6
7
7
8
8
8
8
9
9
10
11
12
12
13
12
13
13
13
14
14
15
15
17
16
16
16
17
20
Interest
4
4
3
5
4
5
6
7
5
4
4
5
4
4
3
3
3
3
3
4
2
4
4
4
3
1
2
2
5
Profit Before Tax
1
5
6
8
8
12
16
17
20
29
32
24
12
28
18
24
14
53
39
110
83
122
105
92
130
49
128
39
18
Tax
0
1
1
2
2
4
5
27
5
7
5
7
3
7
5
3
4
15
8
26
21
32
23
25
32
17
26
12
4
Net Profit
1
5
5
7
6
9
11
-9
15
21
27
17
9
20
13
22
10
39
31
85
62
89
81
68
98
33
102
28
14
EPS in ₹
0.44
3.55
3.66
5.17
4.45
6.77
8.66
-7.25
11.82
16.71
20.84
13.48
6.81
15.88
10.08
16.97
7.77
29.97
23.81
65.90
48.23
69.56
63.44
52.66
76.28
25.60
79.18
21.67
10.83

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
512
524
886
1,071
1,130
1,231
1,325
1,384
1,580
1,833
2,180
Fixed Assets
123
139
466
475
542
653
716
767
758
824
955
Current Assets
316
314
375
447
454
515
550
581
761
921
1,140
Capital Work in Progress
42
41
20
126
105
24
17
21
41
46
48
Investments
0
0
8
8
8
8
7
4
1
1
109
Other Assets
347
345
393
463
477
547
585
592
781
962
1,068
Total Liabilities
512
524
886
1,071
1,130
1,231
1,325
1,384
1,580
1,833
2,180
Current Liabilities
295
268
286
367
327
358
369
363
439
428
466
Non Current Liabilities
55
69
54
146
104
163
170
180
147
122
189
Total Equity
162
187
546
558
699
710
787
841
994
1,283
1,525
Reserve & Surplus
152
178
537
549
686
697
774
828
981
1,270
1,512
Share Capital
9
9
9
9
13
13
13
13
13
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
1
-4
-0
5
3
-9
3
40
42
44
Investing Activities
-14
-20
-42
-116
-77
-49
-85
-95
-61
-150
-298
Operating Activities
13
45
39
11
70
57
189
60
237
261
317
Financing Activities
1
-24
-0
105
12
-6
-114
38
-136
-69
25

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
36.22 %
36.22 %
36.22 %
36.22 %
36.22 %
36.22 %
36.22 %
36.14 %
36.14 %
36.03 %
35.97 %
32.80 %
32.74 %
32.72 %
32.64 %
32.68 %
32.68 %
32.68 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
21.57 %
22.69 %
24.44 %
25.72 %
26.46 %
23.86 %
22.11 %
21.69 %
DIIs
0.87 %
0.04 %
0.80 %
0.80 %
0.80 %
0.80 %
6.58 %
6.55 %
7.10 %
6.76 %
6.99 %
6.03 %
6.54 %
6.39 %
6.38 %
9.08 %
10.97 %
11.57 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.44 %
0.46 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
Public / Retail
34.06 %
36.62 %
33.19 %
32.84 %
32.43 %
33.25 %
31.03 %
30.09 %
29.86 %
29.01 %
27.86 %
29.51 %
27.97 %
27.05 %
26.50 %
26.05 %
25.86 %
25.55 %
Others
28.85 %
27.12 %
29.80 %
30.15 %
30.56 %
29.74 %
25.73 %
26.76 %
26.51 %
27.80 %
7.21 %
8.57 %
7.91 %
7.71 %
7.61 %
7.93 %
7.99 %
8.12 %
No of Share Holders
0
22,412
34,978
34,332
32,426
32,257
31,976
30,600
26,948
25,223
26,824
27,723
28,616
29,077
34,567
39,315
39,333
42,419

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 2 5 5 10 14 12
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.1 0.49 0.28 0.16 0.12 0.09

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
31 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jul 2025 12,306.00 13,914.00
30 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Jul 2025 12,472.30 13,849.10
18 Jul 2025 DIVIDEND Dividend
₹ 12.00 /share
18 Jul 2025 12,472.30 14,496.35
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 12,820.80 12,472.30
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2025 13,869.35 14,247.35
06 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2024 16,250.70 15,858.20
31 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2024 7,146.85 9,051.20
13 Jul 2024 DIVIDEND Dividend
₹ 14.00 /share
12 Jul 2024 7,146.85 8,094.80
12 Jul 2023 DIVIDEND Dividend
₹ 10.00 /share
11 Jul 2023 2,115.25 2,998.80
15 Jul 2022 DIVIDEND Dividend
₹ 5.00 /share
14 Jul 2022 1,334.25 1,298.00
01 Jul 2021 DIVIDEND Dividend
₹ 3.00 /share
29 Jun 2021 2,692.70 2,142.20

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome3 days ago
Update On Outcome Of Board Meeting And Change In Directorate Disclosures Regarding Appointment Of Additional Director3 days ago
Announcement under Regulation 30 (LODR)-Change in Directorate3 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation3 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release3 days ago
Unaudited Financial Results For Quarter Ended June 30 20253 days ago
Board Meeting Outcome for Unaudited Financial Results For Quarter Ended June 30 20253 days ago
Shareholder Meeting / Postal Ballot-Scrutinizers Report4 days ago
Shareholder Meeting / Postal Ballot-Outcome of AGM4 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication9 days ago
Addendum To The Notice Of 41St Annual General MeetingJul 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 15, 2025
Disclosure Under Regulation 30 Of SEBI Listing RegulationsJul 15, 2025
Clarification sought from Neuland Laboratories LtdJul 15, 2025
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30 2025Jul 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 05, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jul 04, 2025
Notice Of 41St Annual General MeetingJul 04, 2025
Reg. 34 (1) Annual Report.Jul 04, 2025
Disclosure Under Regulation 30 Of SEBI Listing RegulationsJun 28, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJun 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 19, 2025
Disclosure Under Regulation 30 Of SEBI Listing RegulationsJun 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 17, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJun 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 11, 2025
Compliance Certificate Pursuant To SEBI Exemption Order Dated January 3 2025 For The Financial Year Ended March 31 2025Jun 10, 2025
Clarification sought from Neuland Laboratories LtdJun 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 19, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateMay 19, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 15, 2025
41St Annual General Meeting Of The Shareholders Of The Company Is Scheduled To Be Held On Wednesday July 30 2025May 15, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 15, 2025
The Record Date For The Purpose Of Determining The Shareholder Eligible To Receive The Final Dividend For The Financial Year Ended March 31 2025 Has Been Fixed As July 18 2025May 15, 2025
Appointment Of Secretarial Auditors Of The CompanyMay 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 15, 2025
Corporate Action-Board approves DividendMay 15, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 15, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2025
Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2024-25May 15, 2025
Board Meeting Outcome for Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2024-25May 15, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 05, 2025

Technical Indicators

RSI(14)
Neutral
47.26
ATR(14)
Volatile
653.14
STOCH(9,6)
Neutral
27.31
STOCH RSI(14)
Oversold
13.79
MACD(12,26)
Bearish
-104.21
ADX(14)
Strong Trend
31.27
UO(9)
Bearish
44.37
ROC(12)
Downtrend And Accelerating
-14.77
WillR(14)
Neutral
-73.59

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
ICICI Prudential Flexicap Fund Direct - Growth
1.51%
28274
0.21%
0.16%
HSBC Small Cap Fund Direct-Growth
1.57%
-9392
-0.09%
-0.56%
JM Small Cap Fund Direct - Growth
1.20%
-2066
-0.35%
-1.40%
UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund Direct-Growth
0.48%
286
0.48%
0.48%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.51%
267
-0.01%
-0.08%
Axis Nifty Smallcap 50 Index Fund Direct-Growth
1.46%
196
-0.03%
-0.23%
ITI Pharma and Healthcare Fund Direct - Growth
2.08%
178
0.10%
0.11%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.51%
115
-0.01%
-0.08%
HDFC BSE 500 Index Fund Direct - Growth
0.05%
112
0.05%
0.05%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.20%
111
0.02%
0.00%
Kotak Nifty Smallcap 50 Index Fund Direct - Growth
1.45%
73
-0.05%
-0.23%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.51%
53
-0.01%
-0.08%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.51%
50
-0.01%
-0.08%
Aditya Birla Sun Life Nifty Smallcap 50 Index Fund Direct-Growth
1.45%
43
-0.04%
-0.23%
Tata Nifty MidSmall Healthcare Index Fund Direct - Growth
1.74%
39
-0.04%
-0.13%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.13%
-19
0.00%
-0.02%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.51%
16
-0.01%
-0.08%
Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth
1.73%
-11
-0.04%
-0.13%
Kotak Nifty Smallcap 250 Index Fund Direct-Growth
0.50%
9
-0.01%
-0.09%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.05%
8
0.00%
0.00%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.51%
8
-0.01%
-0.08%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.51%
5
-0.01%
-0.08%
Tata Nifty500 Multicap India Manufacturing 50:30:20 Index Fund Direct - Growth
0.52%
5
0.02%
-0.02%
SBI Nifty 500 Index Fund Direct-Growth
0.05%
-3
0.00%
-0.01%
Groww Nifty Total Market Index Fund Direct - Growth
0.05%
2
0.00%
0.00%